Decreased susceptibility of staphylococcus aureus small-colony variants toward human antimicrobial peptides

Journal of Investigative Dermatology

Volumn 134, Issue 9, 2014, Pages 2347-2350

  Gläser, Regine ^a   Becker, Karsten ^b   Von Eiff, Christof ^b,c   Meyer Hoffert, Ulf ^a   Harder, Jürgen ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HEMB PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; BETA DEFENSIN; BETA-DEFENSIN 3, HUMAN; CATHELICIDIN; DEFB4A PROTEIN, HUMAN; DEFENSIN; LL-37 PEPTIDE (17-32), HUMAN; PEPTIDE FRAGMENT; RIBONUCLEASE; RIBONUCLEASE 7;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; CONTROLLED STUDY; HUMAN; NONHUMAN; PRIORITY JOURNAL; SKIN; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; WILD TYPE; ANTIBIOTIC RESISTANCE; HUMAN TISSUE; PHENOTYPE; DISEASE PREDISPOSITION; EPIDERMIS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; STAPHYLOCOCCAL SKIN INFECTION;

BACTERIAL PROTEINS; BETA-DEFENSINS; CATHELICIDINS; DEFENSINS; DISEASE SUSCEPTIBILITY; EPIDERMIS; HUMANS; IMMUNITY, INNATE; PEPTIDE FRAGMENTS; PHENOTYPE; RIBONUCLEASES; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84906310073     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.176     Document Type: Article

References (29)

1. Drake DR, Brogden KA, Dawson DV, et al. (2008). Thematic review series: Skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 49:4-11
2. Gallo RL, Hooper LV. (2012). Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12:503-16
3. Garcia LG, Lemaire S, Kahl BC, et al. (2013). Antibiotic activity against smallcolony variants of Staphylococcus aureus: Review of in vitro, animal and clinical data. J Antimicrob Chemother 68:1455-64
4. Harder J, Bartels J, Christophers E, et al. (2001). Isolation and characterization of human beta-defensin-3, a novel human inducible peptiDe antibiotic. J Biol Chem 276:5707-13
5. Harder J, Dressel S, Wittersheim M, et al. (2010). Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 130:1355-64
6. Harder J, Gläser R, Schröder JM. (2007). Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res 13:317-38
7. Iwatsuki K, Yamasaki O, Morizane S, et al. (2006). Staphylococcal cutaneous infections: Invasion, evasion and aggression. J Dermatol Sci 42:203-14
8. Kisich KO, Howell MD, Boguniewicz M, et al. (2007). The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127:2368-80
9. Koo SP, Bayer AS, Sahl HG, et al. (1996). Staphylocidal action of thrombininduced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun 64:1070-4
10. Kriegeskorte A, Konig S, Sander G, et al. (2011). Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 11:2476-90
11. Köten B, Simanski M, Gläser R, et al. (2009). RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One 4:e6424
12. Melter O, Radojevic B. (2010). Small colony variants of Staphylococcus aureus-review. Folia Microbiol 55:548-58
13. Miller LG, Kaplan SL. (2009). Staphylococcus aureus: A community pathogen. Infect Dis Clin North Am 23:35-52
14. Proctor RA, Von Eiff C, Kahl BC, et al. (2006). Small colony variants: A pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295-305
15. Sadowska B, Bonar A, Von Eiff C, et al. (2002). Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants. FEMS Immunol Med Microbiol 32:191-7
16. Sahly H, Schubert S, Harder J, et al. (2003). Burkholderia is highly resistant to human Beta-defensin 3. Antimicrob Agents Chemother 47: 1739-41
17. Samuelsen O, Haukland HH, Kahl BC, et al. (2005). Staphylococcus aureus small colony variants are resistant to the antimicrobial peptiDe lactoferricin B. J Antimicrob Chemother 56:1126-9
18. Sass V, Schneider T, Wilmes M, et al. (2010). Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78:2793-800
19. Schibli DJ, Hunter HN, Aseyev V, et al. (2002). The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277:8279-89
20. Schröder JM. (2010). Purification of antimicrobial peptides from human skin. Methods Mol Biol 618:15-30
21. Simanski M, Dressel S, Gläser R, et al. (2010). RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol 130:2836-8
22. Tuchscherr L, Medina E, Hussain M, et al. (2011). Staphylococcus aureus phenotype switching: An effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3:129-41
23. Vaudaux P, Kelley WL, Lew DP. (2006). Staphylococcus aureus small colony variants: Difficult to diagnose and difficult to treat. Clin Infect Dis 43: 968-70
24. Von Eiff C, Becker K. (2007). Small-colony variants (SCVs) of staphylococci: A role in foreign body-Associated infections. Int J Artif Organs 30:778-85
25. Von Eiff C, Becker K, Metze D, et al. (2001). Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis 32:1643-7
26. Von Eiff C, Heilmann C, Proctor RA, et al. (1997). A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179:4706-12
27. Von Eiff C, Peters G, Becker K. (2006). The small colony variant (SCV) concept-The role of staphylococcal SCVs in persistent infections. Injury 37(Suppl 2): S26-S33
28. Wittersheim M, Cordes J, Meyer-Hoffert U, et al. (2013). Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta-defensin-2 and-3 in healthy human skin. Exp Dermatol 22:364-6
29. Wos-Oxley ML, Plumeier I, Von Eiff C, et al. (2010). A poke into the diversity and associations within human anterior nare microbial communities. ISME J 4:839-51.